PHASE-II STUDY OF RECOMBINANT ALPHA-2 INTERFERON IN RESISTANT MULTIPLE-MYELOMA

[11] DURIE BGM, 1982, CLIN HAEMATOL, V11, P181

[12] LEUKOCYTE INTERFERON-INDUCED TUMOR-REGRESSION IN HUMAN METASTATIC BREAST-CANCER, MULTIPLE-MYELOMA, AND MALIGNANT-LYMPHOMA [J]. ANNALS OF INTERNAL MEDICINE, 1980, 93 (03) : 399 - 406

[13] LAKELEWIN D, 1979, CANCER TREAT REP, V63, P1403

[14] MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163

[15] MELLSTEDT H, 1979, LANCET, V1, P245

[16] MELLSTEDT H, 1982, IMMUNOTHERAPY HUMAN, P387

[17] MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO

[18] 2-6

[19] PRODUCTION AND PREPARATION OF HUMAN LEUKOCYTE INTERFERON [J]. PHARMACOLOGY & THERAPEUTICS PART A-CHEMOTHERAPY TOXICOLOGY AND METABOLIC INHIBITORS, 1977, 1 (04): : 369 - 381

[20] PRESANT CA, 1978, CANCER, V42, P1222, DOI 10.1002/1097-0142(197809)42:3<1222::AID-CNCR2820420329>3.0.CO

[11] DURIE BGM, 1982, CLIN HAEMATOL, V11, P181

[12] LEUKOCYTE INTERFERON-INDUCED TUMOR-REGRESSION IN HUMAN METASTATIC BREAST-CANCER, MULTIPLE-MYELOMA, AND MALIGNANT-LYMPHOMA [J]. ANNALS OF INTERNAL MEDICINE, 1980, 93 (03) : 399 - 406

[13] LAKELEWIN D, 1979, CANCER TREAT REP, V63, P1403

[14] MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163

[15] MELLSTEDT H, 1979, LANCET, V1, P245

[16] MELLSTEDT H, 1982, IMMUNOTHERAPY HUMAN, P387

[17] MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO

[18] 2-6

[19] PRODUCTION AND PREPARATION OF HUMAN LEUKOCYTE INTERFERON [J]. PHARMACOLOGY & THERAPEUTICS PART A-CHEMOTHERAPY TOXICOLOGY AND METABOLIC INHIBITORS, 1977, 1 (04): : 369 - 381

[20] PRESANT CA, 1978, CANCER, V42, P1222, DOI 10.1002/1097-0142(197809)42:3<1222::AID-CNCR2820420329>3.0.CO